The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Precisely Controlling the Activation of an Iron-Locked Drug Generator in the Liver Sinusoid to Enhance Barrier Penetration and Reduction of Liver Fibrosis
Abstract
Complex physical barriers and the nanomaterial's clearance mechanism in the liver greatly hinder the feasibility of using a conventional liver-targeting nanoplatform to deliver antifibrotic drugs to pathological sites for the treatment of liver fibrosis. Here, a novel drug delivery strategy was designed to overcome drug penetration barriers in a fibrotic liver and cooperated with oral nattokinase (NKase)-mediated antifibrosis therapy as a proof of concept, which relies on the coadministration of a nanosized iron-locked drug generator (named Pro-HAase) and orally absorbed iron chelator deferasirox (DFX). Such a strategy starts from the rapid accumulation of intravenously injected Pro-HAase in the microcapillaries of the fibrotic liver followed by disrupting the polyphenol-iron coordination inside Pro-HAase by DFX, liberating antifibrotic components, including procyanidine (PA) and hyaluronidase (HAase). Attractively, absorption of DFX requires the sequential processes of traversing the intestinal mucosa and targeting the liver, which enable DFX to preferentially disassemble Pro-HAase accumulated in the liver sinusoid rather than in systemic circulation or other organs, thus avoiding the off-target activation of Pro-HAase and depletion of the normal iron pool. The in situ disassembly process decreases the sequestration of Pro-HAase by cells of the mononuclear phagocyte system and promotes gradient-driven permeation of therapeutic components to surrounding liver tissues within 2 h, accompanied by biliary excretion of the inactive iron-DFX complex. As a result, the cooperation of Pro-HAase and DFX not only allows NKase-mediated therapy to completely reverse liver fibrosis but also suppresses the chronic hepatotoxicity of residual liver iron after multiple doses of Pro-HAase. The high spatiotemporal precision, unique barrier-penetration mechanism, and self-detoxification ability of this strategy will inspire the rational design of analogous iron-locked nanosystems to improve the therapeutic outcomes of liver fibrosis or other liver diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hepatic stellate cells (HSCs) has long been recognized as a primary source of ECM and a crucial factor in the progression of liver fibrosis (2).”
From Matrix mechanical remodeled carrier-free nanosystem for programmable closed-loop reversal of liver fibrosis via STING alkylation (2025) · cites this paper as [2]
Citations
Cites
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,505
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Noninvasive Imaging of Quantum Dots in Mice
Ballou, B., Lagerholm, B. C., Ernst, L. A., Bruchez, M. P., & Waggoner, A. S. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034153y · Cited by 1,140
Liver sinusoidal endothelial cells: Physiology and role in liver diseases
Poisson, J., Lemoinne, S., Boulanger, C., Durand, F., Moreau, R., Valla, D., & Rautou, P.-E. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.009 · Cited by 1,047
Mechanism of hard-nanomaterial clearance by the liver
Tsoi, K. M., MacParland, S. A., Ma, X.-Z., Spetzler, V. N., Echeverri, J., Ouyang, B., Fadel, S. M., Sykes, E. A., Goldaracena, N., Kaths, J. M., et al. (2016) · Nature Materials · doi:10.1038/nmat4718 · Cited by 1,010
Kim, D., Park, S., Lee, J. H., Jeong, Y. Y., & Jon, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja071471p · Cited by 876
Harrison, S. A., Bashir, M. R., Guy, C. D., Zhou, R., Moylan, C. A., Frias, J. P., Alkhouri, N., Bansal, M. B., Baum, S., Neuschwander-Tetri, B. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32517-6 · Cited by 802
Bertrand, N., Grenier, P., Mahmoudi, M., Lima, E. M., Appel, E. A., Dormont, F., Lim, J.-M., Karnik, R., Langer, R., & Farokhzad, O. C. (2017) · Nature Communications · doi:10.1038/s41467-017-00600-w · Cited by 708
Manzoor, A. A., Lindner, L. H., Landon, C. D., Park, J.-Y., Simnick, A. J., Dreher, M. R., Das, S., Hanna, G., Park, W., Chilkoti, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1683 · Cited by 459
Coordination-Driven Multistep Assembly of Metal–Polyphenol Films and Capsules
Rahim, M. A., Ejima, H., Cho, K. L., Kempe, K., Müllner, M., Best, J. P., & Caruso, F. (2014) · Chemistry of Materials · doi:10.1021/cm403903m · Cited by 399
Role of Nanoparticle Mechanical Properties in Cancer Drug Delivery
Hui, Y., Yi, X., Hou, F., Wibowo, D., Zhang, F., Zhao, D., Gao, H., & Zhao, C.-X. (2019) · ACS Nano · doi:10.1021/acsnano.9b03924 · Cited by 388
Intagliata, N. M., Caldwell, S. H., & Tripodi, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.265 · Cited by 364
Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation
Choi, H. S., & Frangioni, J. V. (2010) · Molecular Imaging · doi:10.2310/7290.2010.00031 · Cited by 351
Breaking Down the Barriers to Precision Cancer Nanomedicine
von Roemeling, C., Jiang, W., Chan, C. K., Weissman, I. L., & Kim, B. Y. S. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.07.006 · Cited by 330
Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy
Gong, H., Chao, Y., Xiang, J., Han, X., Song, G., Feng, L., Liu, J., Yang, G., Chen, Q., & Liu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00068 · Cited by 322
Novel mechanism for translational control in regulation of ferritin synthesis by iron.
Zähringer, J., Baliga, B. S., & Munro, H. N. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.857 · Cited by 319
Liu, F., He, X., Chen, H., Zhang, J., Zhang, H., & Wang, Z. (2015) · Nature Communications · doi:10.1038/ncomms9003 · Cited by 295
Ganson, N. J., Povsic, T. J., Sullenger, B. A., Alexander, J. H., Zelenkofske, S. L., Sailstad, J. M., Rusconi, C. P., & Hershfield, M. S. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.034 · Cited by 273
Selim, M., Foster, L. D., Moy, C. S., Xi, G., Hill, M. D., Morgenstern, L. B., Greenberg, S. M., James, M. L., Singh, V., Clark, W. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30069-9 · Cited by 252
Ma, X., Liang, X., Li, Y., Feng, Q., Cheng, K., Ma, N., Zhu, F., Guo, X., Yue, Y., Liu, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37225-1 · Cited by 243
Self-citationDirect synthesis of amorphous coordination polymers and metal–organic frameworks
Lin, Z., Richardson, J. J., Zhou, J., & Caruso, F. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00474-1 · Cited by 218
Criteria for Iron Deficiency in Patients With Heart Failure
Masini, G., Graham, F. J., Pellicori, P., Cleland, J. G. F., Cuthbert, J. J., Kazmi, S., Inciardi, R. M., & Clark, A. L. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.11.039 · Cited by 193
Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease
Weng, Y., Yao, J., Sparks, S., & Wang, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030523 · Cited by 192
Key, J., Palange, A. L., Gentile, F., Aryal, S., Stigliano, C., Di Mascolo, D., De Rosa, E., Cho, M., Lee, Y., Singh, J., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b04866 · Cited by 190
Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases
Chen, H., McGowan, E. M., Ren, N., Lal, S., Nassif, N., Shad-Kaneez, F., Qu, X., & Lin, Y. (2018) · Biomarker Insights · doi:10.1177/1177271918785130 · Cited by 168
Acoustically triggered mechanotherapy using genetically encoded gas vesicles
Bar-Zion, A., Nourmahnad, A., Mittelstein, D. R., Shivaei, S., Yoo, S., Buss, M. T., Hurt, R. C., Malounda, D., Abedi, M. H., Lee-Gosselin, A., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00971-8 · Cited by 166
Li, J., Chen, C., & Xia, T. (2022) · Advanced Materials · doi:10.1002/adma.202106456 · Cited by 162
Guerrero, A., del Campo, L., Piscaglia, F., Scheiner, B., Han, G., Violi, F., Ferreira, C.-N., Téllez, L., Reiberger, T., Basili, S., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.023 · Cited by 149
Gu, X., Zhang, G., & Zhang, D. (2011) · The Analyst · doi:10.1039/c1an15874k · Cited by 107
A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging
Zhang, H., Guo, Y., Jiao, J., Qiu, Y. N., Miao, Y., He, Y., Li, Z., Xia, C., Li, L., Cai, J., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00975-2 · Cited by 106
Self-citationNanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
Lin, L., Gong, H., Li, R., Huang, J., Cai, M., Lan, T., Huang, W., Guo, Y., Zhou, Z., An, Y., et al. (2020) · Advanced Science · doi:10.1002/advs.201903138 · Cited by 105
Luo, S., Wang, Y., Shen, S., Tang, P., Liu, Z., Zhang, S., & Wu, D. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100954 · Cited by 100
SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis
Natarajan, V., Harris, E. N., & Kidambi, S. (2017) · BioMed Research International · doi:10.1155/2017/4097205 · Cited by 98
Silica nanoparticles induce liver fibrosis via TGF-β1/Smad3 pathway in ICR mice
Yu, Y., Duan, J., Yang, L., Li, Y., Li, J., Yang, M. G., Wang, J., & Sun, Z. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132304 · Cited by 93
Self-citationZhang, L.-F., Wang, X.-H., Zhang, C.-L., Lee, J., Duan, B.-W., Xing, L., Li, L., Oh, Y.-K., & Jiang, H.-L. (2022) · ACS Nano · doi:10.1021/acsnano.2c03858 · Cited by 92
Jones, D. S., Irwin, C. R., Woolfson, A. D., Djokic, J., & Adams, V. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803095 · Cited by 90
Waldmeier, F., Bruin, G. J. M., Glaenzel, U., Hazell, K., Séchaud, R., Warrington, S., & Porter, J. B. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030833 · Cited by 88
Lee, J., Byun, J., Shim, G., & Oh, Y.-K. (2022) · Nature Communications · doi:10.1038/s41467-022-29186-8 · Cited by 79
Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation
Jang, J.-Y., Kim, T.-S., Cai, J., Kim, J., Kim, Y., Shin, K., Kim, K. S., Park, S. K., Lee, S.-P., Choi, E.-K., et al. (2013) · Laboratory Animal Research · doi:10.5625/lar.2013.29.4.221 · Cited by 77
Li, F., Zhao, Y., Cheng, Z., Wang, Y., Yue, Y., Cheng, X., Sun, J., Atabakhshi‐Kashi, M., Yao, J., Dou, J., et al. (2023) · Advanced Materials · doi:10.1002/adma.202212206 · Cited by 71
Lyu, C., Kong, W., Liu, Z., Wang, S., Zhao, P., Liang, K., Niu, Y., Yang, W., Xiang, C., Hu, X., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01019-z · Cited by 67
Self-citationZhang, Y., Pei, P., Zhou, H., Xie, Y., Yang, S., Shen, W., Hu, L. T., Zhang, Y., Liu, T., & Yang, K. (2023) · ACS Nano · doi:10.1021/acsnano.2c12463 · Cited by 67
Self-citationMicrobial production of nattokinase: current progress, challenge and prospect
Cai, D., Zhu, C., & Chen, S. (2017) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-017-2253-2 · Cited by 62
He, H., Xie, Y., Lv, Y., Qi, J., Dong, X., Zhao, W., Wu, W., & Lü, Y. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800711 · Cited by 61
Sun, Q., Li, Y., Shen, W. H., Shang, W., Xu, Y., Yang, J., Chen, J., Gao, W., Wu, Q., Xu, F., et al. (2024) · Advanced Materials · doi:10.1002/adma.202310673 · Cited by 60
Self-citationBril, V., Hadden, R. D. M., Brannagan, T. H., Bar, M., Chroni, E., Rejdak, K., Rivero, A. D., Andersen, H., Latov, N., Levine, T., et al. (2023) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12573 · Cited by 43
Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications
Airola, C., Pallozzi, M., Cerrito, L., Santopaolo, F., Stella, L., Gasbarrini, A., & Ponziani, F. R. (2023) · Cells · doi:10.3390/cells12131712 · Cited by 37
Senescence of Hepatic Stellate Cells by Specific Delivery of Manganese for Limiting Liver Fibrosis
Gu, L., Zhao, C., Wang, Y., Wang, C., Yin, X., Ye, Q., Liu, Y., Zou, X., Wang, L., Zhuge, Y., et al. (2024) · Nano Letters · doi:10.1021/acs.nanolett.3c03689 · Cited by 36
Iron Chelation Therapy as a Modality of Management
Aydınok, Y. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.12.002 · Cited by 31
An, L., Cai, Y., Tian, Q., Lin, J., & Yang, S. (2020) · Science China Materials · doi:10.1007/s40843-020-1434-1 · Cited by 31
Sorafenib-loaded silica-containing redox nanoparticles for oral anti-liver fibrosis therapy
Tran, H. T., Vong, L. B., Nishikawa, Y., & Nagasaki, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.002 · Cited by 31
Nattokinase atherothrombotic prevention study: A randomized controlled trial
Hodis, H. N., Mack, W. J., Meiselman, H. J., Kalra, V. K., Liebman, H. A., Hwang-Levine, J., Dustin, L., Kono, N., Mert, M., Wenby, R. B., et al. (2021) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-211147 · Cited by 27
Self-citationUnmet Needs in Developing Nanoparticles for Precision Medicine
Schwartz, S. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0390 · Cited by 26
Polyphenols: Novel Signaling Pathways
Ricketts, M., & Ferguson, B. S. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666171129204054 · Cited by 21
Berdoukas, V., Bohane, T. D., Tobias, V., Silva, K. D., Fraser, I., Aessopos, A., & Lindeman, R. (2005) · The Hematology Journal · doi:10.1038/sj.thj.6200569 · Cited by 20
Cheng, D., Wen, Z., Chen, H., Lin, S., Zhang, W., Tang, X., & Wu, W. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2122635 · Cited by 14
Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia
Taher, A. T., Temraz, S. N., & Cappellini, M. D. (2013) · Expert Review of Hematology · doi:10.1586/17474086.2013.827411 · Cited by 10
Tachibana, T., Kanda, J., Machida, S., Saito, T., Tanaka, M., Najima, Y., Koyama, S., Miyazaki, T., Yamamoto, E. M., Takeuchi, M., et al. (2018) · International Journal of Hematology · doi:10.1007/s12185-017-2396-9 · Cited by 10
Research works printed but not linked: 2
- Wang Z., 2015, Altern. Ther. Health Med., 21, 12
- 10.1177/1177271918785130 · DOI · Paper page
Cited by
Precision Phototherapy Enabled by Decoding Complex Microenvironments
Ding, Q., Qi, M., Li, W., Li, M., Xu, J., Kim, Y., Kim, G., Dong, B., Wang, L., & Kim, J. S. (2025) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5c00488 · Cited by 60
Han, H., Yu, D., Liu, Y., Jia, H., & Liu, W. (2025) · Science Advances · doi:10.1126/sciadv.adz4126 · Cited by 7
Wei, C., Shan, X., Huang, Y., Ma, B., Zhao, Z., Fang, Y., Bai, C., Zhang, Z., Zhao, P., Zhang, H., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c16886 · Cited by 5
Huang, S., Wang, K., Ma, Y., Wang, Z., & Tan, M. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.146752 · Cited by 3
Theranostic of neutrophilization nanoparticles
Sun, D., Song, B., Sun, W., Li, A., Gao, Z., & Yu, D. (2026) · Progress in Materials Science · doi:10.1016/j.pmatsci.2026.101699 · Cited by 1
Metadata
- Authors
- Sun, Q., Yang, W., Song, Z., Lu, H., Shang, W., Li, H., Yang, Z., Gao, W., Li, Y., Xu, Y., Luo, M., Liu, K., Wu, Q., Xuan, Z., Shen, W., Yang, Y., & Yin, D.
- Affiliations
- Anhui University of Traditional Chinese Medicine (CN)
- Corresponding author
- Shen, Wei
- Yang, Ye
- Yin, Dengke
- ORCID
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2024-11-25
- Volume
- 146
- Issue
- 49
- Pages
- 33784-33803
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W4404696583
- Cited by
- 6
- References
- 62
- Citations by year
- 2026: 3 · 2025: 3
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of the American Chemical Society (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Anhui Provincial Department of Education (2022AH040077, 2022AH040080, 2023AH030065)
- Anhui University of Chinese Medicine (2021ZC06)
- National Natural Science Foundation of China (52203154)
- Anhui Province (2022xscx100, gxbjZD2022027)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- liver fibrosis, deferasirox, nattokinase, hyaluronidase, procyanidins, liver-targeted drug delivery, iron chelation, liver sinusoids, barrier penetration, antifibrotic therapy, hepatotoxicity, biliary excretion, reticuloendothelial system
- MeSH terms
- Deferasirox, Animals, Humans, Iron, Iron Chelating Agents, Liver, Liver Cirrhosis, Drug Delivery Systems, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.